|« Previous month||Next month »|
21-Dec-2012 - Test you knowledge of the key developments in the Outsourcing sector in 2012 with our festive news quiz.
20-Dec-2012 - BASF says it will not extend its offer for pharmaceutical-grade omega-3 supplier Pronova BioPharma ASA beyond new mid-January deadline.
19-Dec-2012 - The working year is almost done, time to pause from ‘the business’ and embrace the festive season…go on, give it a big hug. Happy holidays!
18-Dec-2012 - Outsourcing-pharma is pleased to showcase its brand new design layout with intuitive navigation and deeper user experience in mind, in an effort to deliver news in an even more efficient way....
17-Dec-2012 - Quintiles is likely to benefit from Big Pharma demand for strategic deals and small pharma’s lack of in-house capacity according to S&P.
14-Dec-2012 - The end of the world is likely to have a negative impact on clinical trials according to research published in the journal of the Canadian Medical Association.
13-Dec-2012 - International Chemical Investors Group (ICIG) has bought Tessenderlo's underperforming European pharmaceutical intermediates and API business.
13-Dec-2012 - Catalent Pharma Solutions will supply Japanese CMO Unigen with cell lines under an agreement announced today.
12-Dec-2012 - Leading CROs have welcomed the flexibility of new US FDA preclinical testing guidelines for cellular and gene therapies as a positive first step.
12-Dec-2012 - Kemwell AB says new contract from Mercury Pharma is further proof that Sweden is an attractive place for pharmaceutical production.
12-Dec-2012 - Last week, BASF officially opened a pharmaceutical grade omega-3 active pharmaceutical ingredient (API) facility on the Isle of Lewis, Scotland that it gained with the acquisition of Equateq earlier this year ....
11-Dec-2012 - Collaborations and expansions dominate Outsourcing-pharma.com’s roundup of developments in the CRO space, with news from Cenduit, Perceptive Informatics, INC Reseach and Spaulding Clinical Research.
11-Dec-2012 - Harlan Laboratories has followed 2011 cutbacks and consolidation measures with plans to invest and expand its preclinical services site in Itingen, Switzerland.
10-Dec-2012 - Quintiles expects to support Alimera Sciences’ efforts to gain UK approval for a diabetic vision loss treatment already deemed too expensive by NICE.
10-Dec-2012 - QPS Holdings has set up a joint venture (JV) partnership with intellim Corporation to set up a new CRO in Japan.
06-Dec-2012 - UK CMO Aesica Pharmaceutical says that working with academia to access cutting edge technologies is critical for contractors that want to meet the demands of the modern drug industry.
06-Dec-2012 - Chemi Pharmaceutical CEO says sabotage by former employee behind accusations of falsified test results that prompted Canadian regulators to suspend license.
06-Dec-2012 - Contract manufacturing organisation (CMO) AMRI has had its largest commercial supply contract renewed by GE Healthcare.
05-Dec-2012 - The GDUFA ‘self-identification’ requirement for generic API plants is not a flawed idea says SOCMA’s BDTF after FDA extends registration deadline citing fewer than expected registrations.
05-Dec-2012 - GE Healthcare says new cell science lab in Wales will save drugmakers time and money and create more accurate alternatives to animal-based drug toxicity testing models.
05-Dec-2012 - Researchers say cluster randomized trials (CRTs) present "distinct ethical challenges" and have created 15 "guidelines" to help researchers and ethics committees address them.
05-Dec-2012 - Swedish CRO Trial Form Support International (TFS) has bought Italian counterpart Dimensione Ricerca to strengthen its presence in Southern Europe and key therapeutic areas like oncology.
05-Dec-2012 - Covance says SFDA GLP certification for Shanghai early-phase facility will save sponsors time and money in China and elsewhere.
04-Dec-2012 - Guidance issued by Icon is at the lower end of consensus estimates but it still suggests that the CROs margins are set to improve.
04-Dec-2012 - Swedish CMO Recipharm has added capacity for analytical services and stability studies at its laboratory in Solna, Sweden
04-Dec-2012 - NextPharma has sold its US contract manufacturing business Bioserv to private equity group Kesa Partners.
04-Dec-2012 - India's national Atomic Energy Regulation Board (AERB) has approved GVK Biosciences to perform certain isotope-labeling research in its facility, according to the Hyderabad-based contract research organization (CRO).
03-Dec-2012 - The group whose comments on sponsor oversight drew criticism from ACRO says the industry group's preferred ‘trust and verify’ model only works if verification efforts are robust.
03-Dec-2012 - AMRI says the decision to close its second discovery services facility in a year and shift work to Asia reflects changing market demand.
|« Previous month||Next month »|